Rygård Sofie Louise, Kjær Maj-Brit Nørregaard, Perner Anders
Ugeskr Laeger. 2018 Jun 25;180(26).
Clinical trials are important to ensure that patients and society benefit from healthcare interventions. Among the Danish public research investments in medical sciences the main part of funding is given to preclinical and translational research, and less than ten per cent is given to clinical trials. This imbalance may have negative consequences for patients and society, because public investment in clinical trials is likely to ensure broader availability of tested interventions independent of diseases, patient groups, caregivers and clinical settings.
临床试验对于确保患者和社会从医疗干预中受益至关重要。在丹麦对医学科学的公共研究投资中，主要资金用于临床前和转化研究，用于临床试验的不到10%。这种不平衡可能会给患者和社会带来负面影响，因为对临床试验的公共投资可能会确保经过测试的干预措施更广泛地可得，而不受疾病、患者群体、护理人员和临床环境的限制。
